SLS - SELLAS Life Sciences Group, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development8,7676,06711,3954,871
Selling General and Administrative12,7729,3894,5932,921
Non Recurring----
Total Operating Expenses21,53915,45615,9887,792
Operating Income or Loss-21,539-15,456-15,988-7,792
Income from Continuing Operations
Total Other Income/Expenses Net-7,509-8,045-1,692-439
Earnings Before Interest and Taxes-21,539-15,456-15,988-7,792
Interest Expense-266-462-1,166-552
Income Before Tax-29,048-23,501-17,680-8,231
Income Tax Expense-1,3782531-
Minority Interest----
Net Income From Continuing Ops-27,670-23,754-17,681-8,231
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-27,670-23,754-17,681-8,231
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-41,251-24,429-17,681-8,231